60
Views
6
CrossRef citations to date
0
Altmetric
Review

Exenatide extended-release; clinical trials, patient preference, and economic considerations

Pages 35-45 | Published online: 09 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Heather N Woodward & Sarah L Anderson. (2014) Once-weekly albiglutide in the management of type 2 diabetes: patient considerations. Patient Preference and Adherence 8, pages 789-803.
Read now

Articles from other publishers (5)

Takahiro Takase, Akinobu Nakamura, Chiho Yamamoto, Hiroshi Nomoto, Aika Miya, Midori Dannoura, Kyu Yong Cho, Yoshio Kurihara, Naoki Manda, Shin Aoki, Tatsuya Atsumi & Hideaki Miyoshi. (2018) Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial. Journal of Diabetes Investigation 10:3, pages 699-705.
Crossref
W. M. Valencia & H. Florez. (2014) Pharmacological treatment of diabetes in older people. Diabetes, Obesity and Metabolism 16:12, pages 1192-1203.
Crossref
A. Penfornis & J.-P. Sauvanet. (2014) Agonistes du récepteur du GLP-1 en une injection hebdomadaire : quelles perspectives pour le patient diabétique de type 2 ?. Médecine des Maladies Métaboliques 8:6, pages 612-622.
Crossref
K.A. Hlavaty, R.F. Gibly, X. Zhang, C.B. Rives, J.G. Graham, W.L. LoweJrJr, X. Luo & L.D. Shea. (2014) Enhancing Human Islet Transplantation by Localized Release of Trophic Factors From PLG Scaffolds. American Journal of Transplantation 14:7, pages 1523-1532.
Crossref
Fiorenzo Santoleri, Paola Sorice, Ruggero Lasala & Alberto Costantini. (2014) Liraglutide vs Exenatide: Patient Adherence, Medication Persistence and Economic Evaluation in the Treatment of Type 2 Diabetes Mellitus. Pharmacology & Pharmacy 05:04, pages 332-339.
Crossref